Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 08 - 04 tags : Biotechnology save search
INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease
Published: 2021-08-04 (Crawled : 13:00) - biospace.com/
INO 2 d | $11.05 14.69% 12.81% 700K
|
Health Technology
|
| O: -6.97%
H: 13.21%
C: 9.36%
disease phase 2 respiratory vaccine trial syndros
A Pivotal Moment For CRISPR In the Gene Editing Journey
Published: 2021-08-04 (Crawled : 13:00) - biospace.com/
REGN | $901.27 0.8% 0.78% 470K
|
Health Technology
|
| O: -0.27%
H: 2.35%
C: -0.68%
crispr
Alzamend Neuro Announces Additional Investment Under Its Investigational New Drug Application for AL001 for Dementia Related to Alzheimer’s Pursuant to the Securities Purchase Agreement with Digital Power Lending
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
ALZN | $0.7241 -5.01% -5.28% 58K
|
Professional, Scientific, and T...
|
| O: 3.49%
H: 2.02%
C: -2.25%
new drug alzheimer dementia drug al001 alzheimer’s alzheimer's
Akouos to Present at Upcoming August 2021 Virtual Investor Conferences
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
AKUS | $13.29 1.07% 3.46%
|
Health Technology
|
| O: -0.89%
H: 4.38%
C: 3.76%
conference
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.